Heart health company Omron Healthcare Inc reported on Thursday the receipt of US FDA clearance for Complete, the first blood pressure monitor with EKG capability in a single device.
The company will open Complete pre-orders on 15 April in the US on OmronHealthcare.com for USD199.99, with retail availability expanding to Amazon beginning 1 May 2019.
According to the company, Complete is an upper arm blood pressure monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. EKG readings can be measured by touching electrodes located on the top face and both sides of the monitor for easy access and comfort.
EKG is an essential measurement for those with atrial fibrillation, also known as arrythmia or Afib, which can lead to increased risk of stroke and heart failure. Complete uses an advanced new algorithm for improved detection of the possibility of Afib along with medical-grade blood pressure measurement.
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
Abbott's Navitor TAVI system granted CE Mark for expanded indication